Improving Global Tuberculosis Control With The AuTuMN Platform
Funder
National Health and Medical Research Council
Funding Amount
$655,059.00
Summary
Tuberculosis (TB) is the world’s leading infectious killer, with the failure of global control responsible for the vast majority of Australia’s cases. Using our robustly developed software platform, we have performed several country-level studies to predict the future burden of disease and compare the impact of alternative responses to controlling the epidemic. In this project, we will extend our platform to perform simulations at the global level and answer key questions in TB control.
Preterm birth is a major cause of neonatal death and cerebral palsy. This grant will provide proof-of-concept that a computer program can be developed to predict a pregnant woman�s risk of preterm birth. There is a large market (4M US and 8M Europe), there are no competing technologies. This is a unique collaboration between Biomedical Engineering and an Australian centre with an international reputation in preterm birth, assisted by a pathology company.
Adequate nutrition is necessary for recovery from illness. 30-40% of hospitalised patients may be malnourished. The critically ill are at higher risk because of increased energy requirements yet often receive less than 50% of required nutritional intake. Adequate nutrition therapy is associated with improved patient outcomes, such as reduced mortality and reduced infectious complications. Robust strategies to implement of evidence-based recommendations for nutrition therapy are required.
A Randomised Open-label Study Comparing The Safety And Efficacy Of Two Alternative Treatment Options In The Management Of HIV-1 Infected Participants Who Have Virologically Failed A Standard First-line Combination ART Regimen
Funder
National Health and Medical Research Council
Funding Amount
$457,676.00
Summary
For the past decade there has been an unprecedented international effort to provide access to care for all HIV-infected people as a basic human right. Most of these people are treated with a simple combination of drugs that are well proven to control HIV. However, what to do when this first drug combination stops working is unknown. This study aims to fill that knowledge gap so that patients failing the first drug combination can be offered a second combination with a maximal chance of success.
Reliability Of An Online Geriatric Assessment Procedure
Funder
National Health and Medical Research Council
Funding Amount
$343,822.00
Summary
This study will examine the reliability, safety and cost of a novel new method of providing geriatrician assessment to older people in hospital. Nurses consult with the patient and enter their findings on a web-based software system that enables the geriatrician to review, report and make recommendations over the internet.
Novel Bioinformatics approaches for genetics and data linkage. The research project will involve creation of novel data and communications formats to fulfil the vital task of integrating the vast heterogeneous biological resources available. We will apply this new infrastructure to a large data linkage project. In parallel, we will undertake methodological research in informatics to design high throughput research methods and tools to analyse and visualise genetic data. These will be applied to ....Novel Bioinformatics approaches for genetics and data linkage. The research project will involve creation of novel data and communications formats to fulfil the vital task of integrating the vast heterogeneous biological resources available. We will apply this new infrastructure to a large data linkage project. In parallel, we will undertake methodological research in informatics to design high throughput research methods and tools to analyse and visualise genetic data. These will be applied to linkage disequilibrium mapping and haplotyping in human, animal and plant diseases. Improving informatics integration and designing novel methods and implementations of algorithms will be beneficial to local and international researchers in a range of fields.Read moreRead less
An In Depth Analysis Of Clinical And Virological Outcomes Of 2 Strategies For The Antiretroviral Salvage Of First-line Regimen Virological Failure For HIV-1 Infection Tested In An Australian-led Randomised, International, Multi-centre Clinical Trial
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
The recently completed Australian-led SECOND-LINE trial is the first high quality study to provide reliable evidence for policy recommendations for the composition of anti-HIV drug cocktails after standard initial treatment has failed. This award will support the researcher in further refining our understanding of how to manage second-line therapy including proposals to test the use of low-cost technologies for application in resource-limited settings where the majority of people with HIV live.
An Economical, Robust Alternative Braille Transcription Device. The Curtin University Brailler (CUB). Braille is an important language used by the blind to read and write and Braillers are needed for everyday communication. This justifies the development of a light weight, transportable unit that is accessible at all times. This project proposes a relatively inexpensive, light weight, reliable and easily maintained Braille transcription system. The significant aspects of the proposed brailler in ....An Economical, Robust Alternative Braille Transcription Device. The Curtin University Brailler (CUB). Braille is an important language used by the blind to read and write and Braillers are needed for everyday communication. This justifies the development of a light weight, transportable unit that is accessible at all times. This project proposes a relatively inexpensive, light weight, reliable and easily maintained Braille transcription system. The significant aspects of the proposed brailler include;
- An Electromagnetically compatable (EMC)12 Volt Power Supply allowing the common car battery as a backup power source.
- Use of modern plastics (PTFE) to reduce weight, maintenance and EMC standards.
- An embedded system for Forward and Back translation of literary Braille
- Protocol development and specification for USB keyboard and (standard) printer.Read moreRead less
Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network
Funder
National Health and Medical Research Council
Funding Amount
$2,497,654.00
Summary
Arthritis and musculoskeletal conditions place an immense and growing burden on the world’s population. They affect 28% of Australians (>6.1 million people). With the support of CRE funding, the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network will optimise musculoskeletal health through high quality, collaborative clinical research, building research capacity and effective transfer of research outcomes into clinical practice and health policy.